Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 7, 2012

NIH Will Pay for Salary Cap with GEN Poll Predicting Researchers Will Migrate to Industry

  • NIH’s effective $20,000 lowering of the salary cap for principal investigators and officials will have the effect of driving researchers toward potentially higher-paying jobs in industry, according to a majority of voters on a recent GEN poll. About 57.1% of respondents agreed with Jameson & Company, a CPA firm, that this decision “will have a major effect on University NIH Grants, R01s, and SBIR/STTR and the direct salary received from these awards;”  34.9% of voters did not think there would be a migration of scientists to industry, while 7.9% were undecided.

    Lowering the salary cap was directed by the passage of H.R. 2055 last December. The legislation substitutes Executive Level 2, which commands an annual salary of $179,700, for Executive Level I, which paid up to $199,700.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »